Nephro-Urology Monthly
Scopus by Title (Ref)
1. Finerenone and diabetic renal disease: a narrative review
- Venkatesan K. , et al.
2. Development, optimization, and assessment of losartan nano-bilosomes to mitigate diabetes-induced microvascular complications in Sprague Dawley rats
- Qushawy M. , et al.
3. Targeted drug delivery strategy: a bridge to the therapy of diabetic kidney disease
- Chen X. , et al.
4. Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
- Dhore-patil A. , et al.
5. Captopril and Spironolactone can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting ABCA1 and microRNA-33
- Ghaffari T. , et al.
6. Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis
- Villa-Zapata L. , et al.
7. Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
- Kawanami D. , et al.
9. Organoprotective effects of spironolactone on top of ramipril therapy in a mouse model for alport syndrome
- Rubel D. , et al.
10. Mineralocorticoid receptor antagonists in diabetic kidney disease
- Vodošek Hojs N. , et al.
11. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
- Chung E.Y.M. , et al.
12. Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis
- Feng Y. , et al.
13. Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes
- Dong D. , et al.
14. The ascent of mineralocorticoid receptor antagonists in diabetic nephropathy
- Goenka L. , et al.
15. Effect of Kangxianling Decoction on Renal Fibrosis and ACE-Ang II-AT1R Axis in 5/6 Nephrectomized Rats
- Ji J. , et al.
16. Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
- Sun L.J. , et al.
17. Effect of low-dose spironolactone on resistant hypertension in type 2 diabetes mellitus: A randomized controlled trial in a sub-Saharan African population
- Djoumessi R.N. , et al.
18. Reporting quality assessment of randomized controlled trials published in nephrology urology monthly journal
- Mehrazmay A. , et al.
19. Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy
- Wang S. , et al.
20. Drugs targeting RAAS in the treatment of hypertension and other cardiovascular diseases
- Balakumar P. , et al.